BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34443411)

  • 21. Novel 5,7-disubstituted 6-amino-5H-pyrrolo[3,2-b]pyrazine-2,3-dicarbonitriles, the promising protein kinase inhibitors with antiproliferative activity.
    Dubinina GG; Platonov MO; Golovach SM; Borysko PO; Tolmachov AO; Volovenko YM
    Eur J Med Chem; 2006 Jun; 41(6):727-37. PubMed ID: 16675067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structure-activity relationships of pyrazine-pyridine biheteroaryls as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.
    Kuo GH; Prouty C; Wang A; Emanuel S; Deangelis A; Zhang Y; Song F; Beall L; Connolly PJ; Karnachi P; Chen X; Gruninger RH; Sechler J; Fuentes-Pesquera A; Middleton SA; Jolliffe L; Murray WV
    J Med Chem; 2005 Jul; 48(15):4892-909. PubMed ID: 16033269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clitocybe alexandri extract induces cell cycle arrest and apoptosis in a lung cancer cell line: Identification of phenolic acids with cytotoxic potential.
    Vaz JA; Almeida GM; Ferreira IC; Martins A; Vasconcelos MH
    Food Chem; 2012 May; 132(1):482-6. PubMed ID: 26434319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic, Structural, and Anticancer Activity Evaluation Studies on Novel Pyrazolylnucleosides.
    Yadav Y; Sharma D; Kaushik K; Kumar V; Jha A; Prasad AK; Len C; Malhotra SV; Wengel J; Parmar VS
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31671703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and antitumor activity of triterpenoid pyrazine derivatives from 23-hydroxybetulinic acid.
    Zhang H; Wang Y; Zhu P; Liu J; Xu S; Yao H; Jiang J; Ye W; Wu X; Xu J
    Eur J Med Chem; 2015 Jun; 97():235-44. PubMed ID: 25984840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, antitumor screening and cell cycle analysis of novel benzothieno[3,2-b]pyran derivatives.
    Zaher AF; Abuel-Maaty SM; El-Nassan HB; Amer SA; Abdelghany TM
    J Enzyme Inhib Med Chem; 2016; 31(sup4):145-153. PubMed ID: 27590401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
    Kassab AE; Hassan RA
    Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of novel 7-aminosubstituted pyrido[2,3-b]pyrazines exhibiting anti-breast cancer activity.
    Argyros O; Lougiakis N; Kouvari E; Papafotika A; Raptopoulou CP; Psycharis V; Christoforidis S; Pouli N; Marakos P; Tamvakopoulos C
    Eur J Med Chem; 2017 Jan; 126():954-968. PubMed ID: 28006668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
    Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
    Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Tripentone Analogs with Antiproliferative Activity.
    Parrino B; Ullo S; Attanzio A; Spanò V; Cascioferro S; Montalbano A; Barraja P; Tesoriere L; Cirrincione G; Diana P
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29156549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates.
    Ibáñez E; Plano D; Font M; Calvo A; Prior C; Palop JA; Sanmartín C
    Eur J Med Chem; 2011 Jan; 46(1):265-74. PubMed ID: 21115210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents.
    Ruberte AC; Plano D; Encío I; Aydillo C; Sharma AK; Sanmartín C
    Eur J Med Chem; 2018 Sep; 157():14-27. PubMed ID: 30071406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anticancer activity of new dihydropyrimidinone derivatives.
    Mostafa AS; Selim KB
    Eur J Med Chem; 2018 Aug; 156():304-315. PubMed ID: 30015070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catalyst-Free One-Pot Synthesis of Densely Substituted Pyrazole-Pyrazines as Anti-Colorectal Cancer Agents.
    Xu J; Tan HB; Zhang YJ; Tang DY; Zhan F; Li HY; Chen ZZ; Xu ZG
    Sci Rep; 2020 Jun; 10(1):9281. PubMed ID: 32518332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAF
    Al-Wahaibi LH; Gouda AM; Abou-Ghadir OF; Salem OIA; Ali AT; Farghaly HS; Abdelrahman MH; Trembleau L; Abdu-Allah HHM; Youssif BGM
    Bioorg Chem; 2020 Nov; 104():104260. PubMed ID: 32920363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biological evaluation and molecular modeling study of 2-amino-3,5-disubstituted-pyrazines as Aurora kinases inhibitors.
    Bo YX; Xiang R; Xu Y; Hao SY; Wang XR; Chen SW
    Bioorg Med Chem; 2020 Mar; 28(5):115351. PubMed ID: 32035750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
    Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
    Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of substituted aminopyridazin-3(2H)-ones as G0/G1-phase arresting agents with apoptosis-inducing activities.
    Ge BC; Feng HF; Cheng YF; Wang HT; Xi BM; Yang XM; Xu JP; Zhou ZZ
    Eur J Med Chem; 2017 Dec; 141():440-445. PubMed ID: 29040954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.